Comparative Antimicrobial Activities of the Newly Synthesized Quinolone WQ-3034, Levofloxacin, Sparfloxacin, and Ciprofloxacin against Mycobacterium tuberculosis and Mycobacterium avium Complex

WQ-3034 is a newly synthesized acidic fluoroquinolone. We assessed its in vitro activity against Mycobacterium tuberculosis and M. avium complex using levofloxacin (LVFX), ciprofloxacin (CPFX), sparfloxacin (SPFX), and KRM-1648 (KRM) as reference drugs. The MICs of these agents were determined by th...

ver descrição completa

Detalhes bibliográficos

Publicado no:	Antimicrob Agents Chemother
Principais autores:	Tomioka, Haruaki, Sato, Katsumasa, Kajitani, Hiroko, Akaki, Tatsuya, Shishido, Shinji
Formato:	Artigo
Idioma:	Inglês
Publicado em:	American Society for Microbiology (ASM) 2000
Assuntos:	Susceptibility
Acesso em linha:	https://ncbi.nlm.nih.govhttps://pmc.ncbi.nlm.nih.gov/articles/PMC89672/ https://ncbi.nlm.nih.govhttps://pubmed.ncbi.nlm.nih.gov/10639351/ https://ncbi.nlm.nih.govhttps://doi.org/10.1128/aac.44.2.283-286.2000
Tags:	Adicionar Tag Sem tags, seja o primeiro a adicionar uma tag!